Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Avid Radiopharmaceuticals raises $8.9mm in institutional round

Executive Summary

Molecular imaging company Avid Radiopharmaceuticals raised $8.9mm in an institutional financing round through the sale of Series A and Series B preferred stock to existing and new investors, respectively. Pfizer Strategic Investments Group led the financing, which was also backed by Lilly Ventures, RK Ventures LLC, and seed financer BioAdvance.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies